Rixensart, le 25 avril 2023 – En cette journée mondiale de lutte contre le paludisme, la société pharma GSK, la ministre des Affaires étrangères Hadja Lahbib, UNICEF Belgique et des représentants de l’écosystème pharmaceutique belge se sont réunis pour célébrer le rôle central que jouent les sites belges de GSK dans la lutte contre cette maladie. Développé et fabriqué en Belgique, le premier vaccin mondial contre ce parasite responsable de cette maladie tropicale témoigne d'une solide empreinte belge.
\nTreize collaborateurs belges de GSK, du projet AmbassadRIX, ont témoigné de leur voyage au Ghana pour mieux comprendre les conditions de vaccination dans les pays les plus touchés par les maladies infectieuses. Enfin, GSK et UNICEF Belgique ont annoncé qu’ils intensifieront leur collaboration au Ghana dans les deux années à venir.
\nLes maladies infectieuses impactent fortement de nombreux pays à faible revenu, représentant dans certains cas plus de 70 % de l’ensemble des maladies. Cette situation s'explique en partie par les difficultés d'accès aux soins de santé, notamment aux médicaments et aux vaccins. Près de deux milliards de personnes dans le monde n'ont pas accès aux médicaments et aux vaccins qui pourraient les protéger et les traiter contre ces maladies, réduisant ainsi les taux de mortalité et leur permettant de vivre en bonne santé.
\nGSK s'est engagé depuis longtemps à améliorer la santé mondiale et à accroître l'accès aux médicaments pour ceux qui en ont le plus besoin, comme en témoigne sa position en tête de l'Access to Medicine Index. Son objectif est d’avoir un impact positif sur la santé de 1,3 milliard de personnes dans les pays à faible revenu d’ici 2030. Les opérations de GSK en Belgique jouent un rôle clé dans la réalisation de ces objectifs. Ces 5 dernières années, plus d'un milliard de vaccins, correspondant à plus de 60% des vaccins GSK exportés à partir de la Belgique, étaient destinés à des pays à faible revenu.
\nAvec le développement et la production du vaccin antipaludique RTS,S, recommandé depuis 2021 par l’OMS pour une utilisation à grande échelle dans les régions où la transmission du paludisme par le parasite Plasmodium falciparum est modérée à élevée, GSK poursuit ses efforts. En 2021, 619,000 décès étaient dus à cette maladie dévastatrice*. À ce jour, plus de 1,4 million d'enfants ont reçu au moins une dose du vaccin au Ghana, au Kenya et au Malawi dans le cadre du programme de mise en œuvre de la vaccination antipaludique (MVIP).
\nGSK compte une unité complètement dédiée à cet objectif d’impacter positivement la santé dans les pays à faible revenu - un groupe non commercial doté d'un budget réservé où le succès est mesuré en fonction de l'impact sur la santé, et non du rendement financier. L’ambition de la société s’est traduite également par des investissements continus en Belgique. Par exemple, l’inauguration en 2018 de nouvelles infrastructures entièrement dédiées à la production de vaccins contre la polio.
\nCependant, l’impact de ces nouvelles percées scientifiques est minime si la vaccination dans ces pays ne suit pas. Forts de ce constat, le projet AmbassadRIX a permis à treize collaborateurs aux fonctions variées chez GSK de se rendre en février dernier durant dix jours au Ghana, l’un des trois pays pilotes de la vaccination contre la malaria, afin de mieux comprendre la réalité vaccinale sur le terrain.
\nPour garantir que les innovations de GSK atteignent ceux qui en ont le plus besoin, GSK collabore avec des partenaires tels que l’UNICEF, l'OMS, Gavi, l’Alliance du Vaccin et d’autres. Depuis 2019, GSK collabore avec l'OMS et PATH sur le programme de mise en œuvre de la vaccination antipaludique (MVIP) et commence à travailler de manière plus étroite avec Gavi et l'UNICEF pour s'assurer qu'un plus grand nombre de pays puissent déployer le vaccin avec succès.
\nAujourd’hui, lors de l’événement, GSK et UNICEF Belgique ont annoncé approfondir leur collaboration avec un partenariat structurel de deux ans pour renforcer l’éducation au Ghana. GSK et UNICEF Belgique collaborent depuis 20 ans, et actuellement 160 employés de GSK travaillent comme bénévoles pour UNICEF Belgique en plus de leur travail régulier, collectant des fonds au sein de l'organisation pour soutenir le travail de l'UNICEF. Au cours des deux prochaines années, ces fonds aideront à soutenir les capacités du Ghana en matière d'éducation des jeunes enfants.
\nEmmanuel Amory, administrateur délégué chez GSK : « Nous sommes extrêmement fiers du rôle que jouent nos sites belges dans la lutte contre le paludisme, et déterminés à contribuer à avoir un impact positif sur la santé de 1,3 milliard de personnes dans les pays à faible revenu d'ici 2030. Ces 5 dernières années, plus d'un milliard de vaccins, correspondant à >60% de nos vaccins exportés à partir de la Belgique, étaient destinés à des pays à faible revenu.
\nGrâce au projet AmbassadRIX, le renforcement de notre collaboration avec l’UNICEF au Ghana est apparu comme une évidence pour nous puisqu’il s’agit d’un partenaire avec qui nous travaillons et pour lequel nos employés se mobilisent depuis longtemps. Ce partenariat est un nouvel exemple de l’engagement fort de GSK. »
\nHadja Lahbib, Ministre belge des Affaires étrangères : « Les vaccins sauvent des vies et contribuent à améliorer la santé dans les pays en voie de développement. C'est dans cet esprit que nous célébrons aujourd’hui les efforts de l’UNICEF, de GSK et de l'ensemble de l'écosystème pharmaceutique belge dans la lutte contre le paludisme. Le succès du vaccin antipaludique, développé dans notre pays, témoigne de la force de cet écosystème. La Belgique joue ainsi un rôle de premier plan dans l’amélioration de la santé dans le monde grâce à son savoir-faire et à son expertise. »
\n\n
À propos de GSK
\nGSK est une société biopharmaceutique mondiale dont l'objectif est d'unir la science, la technologie et le talent pour rester ensemble à l'avant-garde de la maladie. GSK vise à avoir un impact positif sur la santé de 2,5 milliards de personnes au cours de la prochaine décennie. La Belgique abrite trois grands sites de recherche, développement et production de vaccins à Wavre, Rixensart et Gembloux.
\nGSK est l'un des principaux fabricants de vaccins au monde, avec un portefeuille de plus de 20 vaccins pour les nourrissons, les adolescents et les adultes ainsi que 20 autres vaccins en développement. Les vaccins sont produits par GSK chaque jour et envoyés aux populations de 158 pays. En Belgique, les plus de 9.000 employés de GSK font d’elle la plus grande entreprise pharmaceutique.
\nContact de presse
\nElisabeth Van Damme - Directrice de la Communication Externe & Public Affairs
+32 478 27 26 41
Elisabeth.e.vandamme@gsk.com
Passez en mode sombre pour participer à la création d'un monde plus durable. Plus d'information ici.
"},"globalSiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"S'ouvre dans une nouvelle fenêtre"},"locationSelector":{"text":"Sélecteur de lieu","href":"/fr-be/location/","openInNewWindowText":null},"healthCareLink":{"text":"Professionnels de la santé","href":"https://gskpro.com/","target":"_blank","openInNewWindowText":"S'ouvre dans une nouvelle fenêtre"},"contactUs":{"text":"Contactez nous","href":"/fr-be/contactez-nous/","openInNewWindowText":null},"search":"Rechercher","backToMain":"Back to main","menu":"Menu","closeMenu":"Fermer le menu","animationsToggleModel":{"enable":true,"activeText":"Mettre la vidéo en pause","inactiveText":"Lire la vidéo"}},"nodes":[{"tooltip":null,"hasBorderRight":false,"title":"Entreprise","url":"/fr-be/entreprise/","nodes":[{"title":"Notre mission, stratégie et culture","url":"/fr-be/entreprise/notre-mission-strategie-et-culture/","nodes":[],"isActive":false},{"title":"GSK Belgique en un coup d'oeil","url":"/fr-be/entreprise/gsk-belgique-en-un-coup-d-oeil/","nodes":[],"isActive":false},{"title":"Politiques, codes et normes","url":"/fr-be/entreprise/nos-politiques-codes-et-normes/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Notre mission, stratégie et culture","image":{"src":"/media/3nyjmu40/gsk_dna_6k_still.png?width=329&height=185&format=webp&quality=100&v=1dc061bb4338070","alt":"DNA branch illustration","darkModeSrc":"/media/3nyjmu40/gsk_dna_6k_still.png?width=329&height=185&format=webp&quality=90&v=1dc061bb4338070"},"link":{"text":"A la une","href":"/fr-be/entreprise/notre-mission-strategie-et-culture/","openInNewWindowText":null}},{"text":"GSK Belgique en un coup d'oeil","image":{"src":"/media/ijdeuu3i/wavre-3.png?width=329&height=185&format=webp&quality=100&v=1dc0dfaf2c53db0","alt":"Production site Wavre","darkModeSrc":"/media/ijdeuu3i/wavre-3.png?width=329&height=185&format=webp&quality=90&v=1dc0dfaf2c53db0"},"link":{"text":"A la une","href":"/fr-be/entreprise/gsk-belgique-en-un-coup-d-oeil/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/fr-be/innovation/","nodes":[{"title":"Domaines thérapeutiques","url":"/fr-be/innovation/domaines-therapeutiques/","nodes":[],"isActive":false},{"title":"Technologies","url":"/fr-be/innovation/technologies/","nodes":[],"isActive":false},{"title":"Etudes cliniques","url":"/fr-be/innovation/etudes-cliniques/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Domaines thérapeutiques","image":{"src":"/media/2jljihdc/gsk_rsv_6k_rgb.jpg?width=329&height=185&format=webp&quality=100&v=1dcb87c9eb32bb0","alt":"RSV virus","darkModeSrc":"/media/2jljihdc/gsk_rsv_6k_rgb.jpg?width=329&height=185&format=webp&quality=90&v=1dcb87c9eb32bb0"},"link":{"text":"A la une","href":"/fr-be/innovation/domaines-therapeutiques/","openInNewWindowText":null}},{"text":"Technologies","image":{"src":"/media/pujjxxef/dnaplustech_12kstilljpg.jpg?width=329&height=185&format=webp&quality=100&v=1dc061bbf15c1b0","alt":"Visuel DNA+Tech","darkModeSrc":"/media/pujjxxef/dnaplustech_12kstilljpg.jpg?width=329&height=185&format=webp&quality=90&v=1dc061bbf15c1b0"},"link":{"text":"A la une","href":"/fr-be/innovation/technologies/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Produits","url":"/fr-be/produits/","nodes":[{"title":"Signaler un effet indésirable","url":"/fr-be/produits/signaler-un-effet-indesirable/","nodes":[],"isActive":false},{"title":"Produits A-Z","url":"/fr-be/produits/produits-a-z/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Découvrez nos produits","image":{"src":"/media/jt4e3r5a/stvg_2_2022_smtlab_10_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dc061bb3ef7290","alt":"Female scientist in a lab with machine","darkModeSrc":"/media/jt4e3r5a/stvg_2_2022_smtlab_10_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dc061bb3ef7290"},"link":{"text":"A la une","href":"/fr-be/produits/","openInNewWindowText":null}},{"text":"L'innovation chez GSK","image":{"src":"/media/p1eedwvd/26626_scientist_walking_through_lab_original.jpg?width=329&height=185&format=webp&quality=100&v=1dc061bb5780e60","alt":"Scientists walking in a lab","darkModeSrc":"/media/p1eedwvd/26626_scientist_walking_through_lab_original.jpg?width=329&height=185&format=webp&quality=90&v=1dc061bb5780e60"},"link":{"text":"A découvrir","href":"/fr-be/innovation/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":true,"title":"Responsabilité","url":"/fr-be/responsabilite/","nodes":[{"title":"Inclusion","url":"/fr-be/responsabilite/notre-culture-d-entreprise/","nodes":[],"isActive":false},{"title":"Normes éthiques","url":"/fr-be/responsabilite/normes-ethiques/","nodes":[],"isActive":false},{"title":"Environnement","url":"/fr-be/responsabilite/environnement/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Inclusion","image":{"src":"/media/wbokb4wv/gskh_3_2022_comspc_30_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dc061bb7df7170","alt":"Two female employees talking at a desk","darkModeSrc":"/media/wbokb4wv/gskh_3_2022_comspc_30_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dc061bb7df7170"},"link":{"text":"A la une","href":"/fr-be/responsabilite/notre-culture-d-entreprise/","openInNewWindowText":null}},{"text":"Environnement","image":{"src":"/media/h3ofkp3p/picture1.jpg?rxy=0.5,0.5013333333333333&width=329&height=185&format=webp&quality=100&v=1dc061bc5dd4a90","alt":"People on a raft navigating on the water in the forest","darkModeSrc":"/media/h3ofkp3p/picture1.jpg?rxy=0.5,0.5013333333333333&width=329&height=185&format=webp&quality=90&v=1dc061bc5dd4a90"},"link":{"text":"A la une","href":"/fr-be/responsabilite/environnement/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Médias","url":"/fr-be/medias/","nodes":[{"title":"Communiqués de presse","url":"/fr-be/medias/communiques-de-presse/","nodes":[],"isActive":true},{"title":"Contacts médias","url":"/fr-be/medias/contacts-medias/","nodes":[],"isActive":false},{"title":"In Focus","url":"/fr-be/medias/in-focus/","nodes":[{"title":"Félicitations aux Lauréats des Prix GSK Vaccins 2025 !","url":"/fr-be/medias/in-focus/felicitations-aux-laureats-des-prix-gsk-vaccins-2025/","nodes":[],"isActive":false},{"title":"GSK remporte l'essenscia Innovation Award 2025 !","url":"/fr-be/medias/in-focus/gsk-remporte-lessenscia-innovation-award-2025/","nodes":[],"isActive":false},{"title":"Les laboratoires QC de GSK Wavre obtiennent la certification \"My Green Lab\"","url":"/fr-be/medias/in-focus/les-laboratoires-qc-de-gsk-wavre-obtiennent-la-certification-my-green-lab/","nodes":[],"isActive":false}],"isActive":false}],"isActive":true,"promos":[{"text":"Communiqués de presse","image":{"src":"/media/zq5llqss/26858_hiv_virus_science_image_4262_additionalfile.jpg?width=329&height=185&format=webp&quality=100&v=1dcb879b6cb4280","alt":"Visuel virus VIH","darkModeSrc":"/media/zq5llqss/26858_hiv_virus_science_image_4262_additionalfile.jpg?width=329&height=185&format=webp&quality=90&v=1dcb879b6cb4280"},"link":{"text":"A la une","href":"/fr-be/medias/communiques-de-presse/","openInNewWindowText":null}},{"text":"Carrières","image":{"src":"/media/ndghdsu5/gskh_2_2022_smtspc_7_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dc061bba7648f0","alt":"Two female employees sitting on an orange couch talking and laughing together","darkModeSrc":"/media/ndghdsu5/gskh_2_2022_smtspc_7_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dc061bba7648f0"},"link":{"text":"A découvrir","href":"/fr-be/carrieres/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Carrières","url":"/fr-be/carrieres/","nodes":[{"title":"Travailler chez GSK","url":"/fr-be/carrieres/travailler-chez-gsk/","nodes":[],"isActive":false},{"title":"Professionnels expérimentés","url":"/fr-be/carrieres/professionnels-experimentes/","nodes":[],"isActive":false},{"title":"Début de carrière","url":"/fr-be/carrieres/debut-de-carriere/","nodes":[],"isActive":false},{"title":"Activités frauduleuses de recrutement en ligne","url":"/fr-be/carrieres/activites-frauduleuses-de-recrutement-en-ligne/","nodes":[],"isActive":false},{"title":"Nos collaborateurs","url":"/fr-be/carrieres/nos-collaborateurs/","nodes":[{"title":"Divyank Gutpa","url":"/fr-be/carrieres/nos-collaborateurs/divyank-gutpa/","nodes":[],"isActive":false},{"title":"Zakaria Zoya","url":"/fr-be/carrieres/nos-collaborateurs/zakaria-zoya/","nodes":[],"isActive":false},{"title":"Yasmina Bahlaouy","url":"/fr-be/carrieres/nos-collaborateurs/yasmina-bahlaouy/","nodes":[],"isActive":false},{"title":"Mercy Fonyuy","url":"/fr-be/carrieres/nos-collaborateurs/mercy-fonyuy/","nodes":[],"isActive":false},{"title":"Julien Vassart","url":"/fr-be/carrieres/nos-collaborateurs/julien-vassart/","nodes":[],"isActive":false},{"title":"Marie Toussaint","url":"/fr-be/carrieres/nos-collaborateurs/marie-toussaint/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Travailler chez GSK","image":{"src":"/media/nsgethp5/gskh_3_2022_comspc_16_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dc061bbb9bb620","alt":"Employees walking up and down the stairs in front of a building","darkModeSrc":"/media/nsgethp5/gskh_3_2022_comspc_16_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dc061bbb9bb620"},"link":{"text":"A la une","href":"/fr-be/carrieres/travailler-chez-gsk/","openInNewWindowText":null}},{"text":"Inclusion","image":{"src":"/media/wbokb4wv/gskh_3_2022_comspc_30_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dc061bb7df7170","alt":"Two female employees talking at a desk","darkModeSrc":"/media/wbokb4wv/gskh_3_2022_comspc_30_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dc061bb7df7170"},"link":{"text":"A découvrir","href":"/fr-be/responsabilite/notre-culture-d-entreprise/","openInNewWindowText":null}}]}],"skipToContent":null,"skipToSearch":null,"typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1703","searchFieldPlaceholderText":"Entrez un terme de recherche...","searchPage":"/fr-be/chercher/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"Ce site est destiné aux visiteurs qui cherchent des informations sur les activités de GSK Belgium.
\n© 2001-2026 GSK Group of Companies. Tous droits réservés. Les marques de commerce sont la propriété du groupe de sociétés GSK ou font l'objet d'une licence.
GlaxoSmithKline Pharmaceuticals s.a./n.v., Avenue Fleming 20, 1300 Wavre, Belgique.
Les informations auxquelles vous allez vous référer peuvent ne pas être conformes aux exigences réglementaires locales. D'autres informations relatives à l'environnement local sont disponibles auprès de la société ou via les informations sur le produit.
","continueText":"Continuer","cancelText":"Annuler","exclusionUrls":["https://www.facebook.com/GSK","http://gsk.com/","http://doingmoreintheus.gsk.com/en-us/map-regions/","https://www.gsk.com","https://www.gsk.com/en-gb/investors/quarterly-results/","https://www.gsk.com/en-gb/about-us/vaccines/why-you-don-t-outgrow-vaccination/","https://www.gsk.com/en-gb/behind-the-science/patients-consumers/eggs-in-manufacturing/","https://innovation.gsk.com/","http://doingmoreintheus.gsk.com/en-us/map-regions/north-carolina/doing-more-on-moore-drive-in-the-research-triangle-park/","http://doingmoreintheus.gsk.com/en-us/map-regions/pennsylvania/gsk-navy-yard-where-we-do-more-with-less/","https://www.gsk.com/en-gb/about-us/save-the-children-partnership","https://www.gskgrants.com","https://www.gskforyou.com/","http://fortherecord.payments.us.gsk.com","https://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","http://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","https://www.gsk.com/en-gb/products/stiefel-dermatology/","https://www.gsk.com/en-gb/products/viiv-healthcare/","https://www.contactus.gsk.com/callback/index.html","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsksource.com/pharma/content/gsk/source/us/en.html","http://www.msds-gsk.com/","https://www.gsk.com/en-gb/investors/shareholder-information/","http://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/investors/corporate-reporting/","https://www.gsk.com/en-gb/investors/product-pipeline/","http://www.gskgrants.com/","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsk.com/media/2941/human-rights-statement-policy.pdf","http://www.gsk.com/media/280848/human-rights-statement-policy.pdf","http://www.gsk.com/en-gb/research/rd-locations/pharmaceuticals/","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","http://twitter.com/GSK","http://www.youtube.com/GSK","http://www.flickr.com/photos/glaxosmithkline","http://www.linkedin.com/company/glaxosmithkline","https://www.instagram.com/gsk/ ","http://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/media/press-releases/new-multi-country-survey-reveals-need-for-improved-awareness-around-long-term-impact-and-appropriate-use-of-corticosteroids-in-sle-management/","http://www.gskforyou.com/","http://us.gsk.com/en-us/behind-the-science/?tag=Corporate+responsibility","https://www.gskforyou.com/prescription-resource-assistance/immunology-respiratory/","https://www.contactus.gsk.com/callback.html","https://www.gsk.com/en-gb/about-us/governance/global-compliance/","https://www.gsk.com/en-gb/careers/physicians/","https://www.gsk.com/en-gb/careers/job-finder/","https://www.gsk.com/en-gb/contact-us/worldwide/","https://access.gsk.com/password/","https://access.gsk.com/selfservice/static/login.jsp?TYPE=33554433&REALMOID=06-c7edf5ec-5585-100d-83b1-84797f88fc89&GUID=&SMAUTHREASON=0&METHOD=GET&SMAGENTNAME=-SM-90R5K5a0NsTyKRhPyTIn3A3B5ovKkqcehflGRUrUNusjZdRaPY%2bWUozEFizs1bMg&TARGET=-SM-https%3a%2f%2fuksah%2egsk%2ecom%2fswh_uk_win_ns%2fcommunications%2femployee%2femployees%2ehtm","https://www.gsk.com/en-gb/responsibility/operating-responsibly/working-with-third-parties/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://ascend.cvmsolutions.com/Account/Login?client=gsk","https://twitter.com/GSKUS","https://twitter.com/GSK","https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf","https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/","https://www.gsk.com/media/2538/gsk-materiality-process.pdf","https://www.gsk.com/en-gb/responsibility/access-to-healthcare/","https://www.gsk.com/en-gb/responsibility/our-people/","https://www.gsk.com/en-gb/responsibility/environment/","https://www.gsk.com/en-gb/responsibility/operating-responsibly/","https://www.gsk.com/media/4552/our-code-of-practice.pdf","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=10","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.instagram.com/gsk/","https://twitter.com/gsk","https://twitter.com/gskus","https://www.youtube.com/GSK","https://www.gsk.com/en-gb/media/resource-centre/","https://www.gsk.com/en-gb/media/image-and-video-library/","https://www.gsk.com/en-gb/media/rss-feeds/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf","https://www.gsk.com/en-gb/careers/meet-our-people/","https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/","https://www.gsk.com/en-gb/careers/postgraduate-opportunities/","https://gskearlytalent.avature.net/landingpage","https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","https://www.gsk.com/en-gb/research/our-approach/open-innovation/","https://www.gsk.com/en-gb/careers/careers-search/?r=USA","https://www.linkedin.com/company/gsk-canada/","https://www.linkedin.com/company/gsk_consumer_healthcare_india/","https://www.linkedin.com/company/gsk-pharmaceuticals-india/","https://www.linkedin.com/company/glaxosmithkline-poland/","https://www.youtube.com/user/gskasiachannel/","https://www.youtube.com/channel/UChWuz9ZDceHYHXmJVJ4hF8Q","https://www.youtube.com/channel/UCN1XeWQWLVhFLHQwZl93jFQ","https://www.youtube.com/channel/UCwQyIfV4pLlsZGuN7fiZm2w","https://twitter.com/gsk_ar","https://twitter.com/GSK_Asia","https://twitter.com/gsk_conferences","https://twitter.com/gsk_au","https://twitter.com/GSK_DE","https://twitter.com/GSKCH_INDIA","https://twitter.com/GSK_IE","https://twitter.com/gsk_it","https://twitter.com/GSKScience","https://twitter.com/stiefel","https://www.gsk.com/en-gb/media/press-releases/karenann-terrell-appointed-chief-digital-technology-officer-gsk/","https://www.gsk.com/en-gb/behind-the-science/innovation/the-digitalisation-lab-bringing-the-digital-age-to-manufacturing/","https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/","http://uk.gsk.com/en-gb/careers/apprenticeships/","https://www.gsk.com/media/4931/gsk-quick-facts.pdf","https://ie.gsk.com/ie/careers/apprenticeships/","http://au.gsk.com/en-au/careers/apprenticeships/","http://sg.gsk.com/en-sg/careers/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/","https://gsk.i-sight.com/landing-page/","https://www.gskforyou.com/","https://jobs.gsk.com/en-us/jobs?keywords=RichmondConsumerHealthcareR%26D&page=1","https://jobs.gsk.com/en-us/jobs?page=1&location=Lincoln,%20NE,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=Carlisle,%20PA,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=East%20Durham,%20NY,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://us.gsk.com/en-us/media/press-releases/fda-approves-parp-inhibitor-in-first-line-monotherapy-maintenance-treatment-for-women-with-platinum-responsive-advanced-ovarian-cancer-regardless-of-biomarker-status/","https://www.gsk.com/en-gb/media/press-releases/gsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthcare-joint-venture/","https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-fight-against-2019-ncov/","https://gskpro.com/fr-be/","https://www.gsk.com/en-gb/research-and-development/our-approach-to-rd/","https://www.gsk.com/en-gb/research-and-development/trials-in-people/","https://www.gsk.com/en-gb/research-and-development/our-use-of-animals/","https://www.gsk.com/en-gb/research-and-development/partnerships/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2020/","https://www.gsk.com/en-gb/responsibility/our-people/inclusion-and-diversity-at-gsk/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2020/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2020/#tab-1-4","https://privacy.gsk.com/fr-be/privacy-notice/general/","https://www.gsk.com/en-gb/","https://www.gsk.com/en-gb/responsibility/operating-responsibly/patient-safety-and-reliable-supply/","https://www.gsk.com/en-gb/responsibility/our-people/employee-engagement/","https://www.gsk.com/en-gb/responsibility/improving-health-globally/pricing-and-access-strategies/","https://www.gsk.com/en-gb/responsibility/improving-health-globally/using-our-science-for-global-health/","https://www.gsk.com/en-gb/","https://www.gsk.com/en-gb/careers/future-leaders/","https://www.gsk.com/media/5326/our-contribution-to-the-sdgs.pdf","https://www.gsk.com/media/5326/our-contribution-to-the-sdgs.pdf","https://www.gsk.com/en-gb/media/press-releases/","https://www.gsk.com/en-gb/#market-selector","https://privacy.gsk.com/en-be/privacy-notice/general","https://privacy.gsk.com/fr-be/privacy-notice/general","https://www.gsk.com/en-gb/behind-the-science-magazine/","https://gskpro.com/fr-be/","https://gsk.i-sight.com/landing-page/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/hiv/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/oncology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/opportunity-driven/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/infectious-diseases/","https://www.info.gsk.com/fr-be/pathologie/vaccination-prevention/meningitis/","https://www.info.gsk.com/fr-be/pathologie/respiratoire/bpco/","https://www.gsk.com/en-gb/behind-the-science-magazine/digital-twin-using-advanced-technology-to-accelerate-vaccine-development/","https://www.gsk.com/en-gb/behind-the-science-magazine/how-adjuvants-boost-our-immune-response/","https://www.gsk-studyregister.com/en/?legacy=true","https://www.gsk.com/en-gb/responsibility/pricing-and-access/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/ethical-standards/","https://www.gsk.com/en-gb/responsibility/product-governance/","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/","https://www.gsk.com/en-gb/responsibility/diversity-equity-and-inclusion/","https://www.gsk.com/en-gb/company/governance/compliance/","https://www.gsk.com/en-gb/behind-the-science-magazine/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_FR","https://gskpro.com/fr-be/","https://gsk.i-sight.com/landing-page/","https://www.gsk.com/en-gb/company/policy-positions/#","https://www.gsk.com/media/8519/the-code-printable-version.pdf","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.gsk.com/en-gb/company/gsk-at-a-glance/","https://www.gsk.com/en-gb/responsibility/","https://www.gsk.com/media/2498/working-with-third-parties.pdf","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2021/","https://www.gsk.com/en-gb/innovation/pipeline/","https://www.gsk.com/en-gb/responsibility/ethical-standards/engaging-with-healthcare-professionals/","https://www.gsk.com/en-gb/responsibility/ethical-standards/use-of-animals/","https://www.gsk.com/en-gb/responsibility/ethical-standards/human-rights/","https://www.gsk.com/en-gb/responsibility/ethical-standards/public-policy-and-patient-advocacy/","https://www.gsk.com/en-gb/responsibility/ethical-standards/working-with-third-parties/","https://www.gsk.com/en-gb/careers/early-talent/future-leaders-graduate-programme/","https://jobs.gsk.com/fr-be/jobs?page=1","https://www.gsk.com/en-gb/behind-the-science-magazine/","https://gsk.i-sight.com/landing-page/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://gskpro.com/nl-be/","https://www.gsk.com/en-gb/locations/israel/","https://www.gsk.com/en-gb/locations/algeria/","https://www.gsk.com/en-gb/locations/egypt/","https://www.gsk.com/en-gb/locations/kazakhstan/","https://www.gsk.com/en-gb/locations/kazakhstan/ru-kz/","https://www.gsk.com/en-gb/locations/kenya/","https://www.gsk.com/en-gb/locations/morocco/","https://www.gsk.com/en-gb/locations/saudi-arabia/","https://www.gsk.com/en-gb/locations/south-africa/","https://www.gsk.com/en-gb/locations/south-africa/","https://www.gsk.com/en-gb/locations/tunisia/","https://www.gsk.com/en-gb/locations/united-arab-emirates/","https://www.gsk.com/en-gb/locations/argentina/","https://www.gsk.com/en-gb/locations/argentina/es-arg/","https://ca.gsk.com/en-ca/","https://ca.gsk.com/fr-ca/","https://www.gsk.com/en-gb/locations/caribbean-islands/","https://www.gsk.com/en-gb/locations/chile/","https://www.gsk.com/en-gb/locations/colombia/","https://www.gsk.com/en-gb/locations/costa-rica/","https://www.gsk.com/en-gb/locations/dominican-republic/","https://www.gsk.com/en-gb/locations/ecuador/","https://www.gsk.com/en-gb/locations/el-salvador/","https://www.gsk.com/en-gb/locations/guatemala/","https://www.gsk.com/en-gb/locations/honduras/","https://www.gsk.com/en-gb/locations/jamaica/","https://www.gsk.com/en-gb/locations/mexico/","https://www.gsk.com/en-gb/locations/nicaragua/","https://www.gsk.com/en-gb/locations/panama/","https://www.gsk.com/en-gb/locations/peru/","https://www.gsk.com/en-gb/locations/trinidad-tobago/","https://us.gsk.com/en-us/","https://www.gsk.com/en-gb/locations/uruguay/","https://www.gsk.com/en-gb/locations/venezuela/","https://au.gsk.com/en-au/","https://www.gsk.com/en-gb/locations/bangladesh/","https://www.gsk.com/en-gb/locations/cambodia/","https://www.gsk-china.com/zh-cn/","https://india-pharma.gsk.com/en-in/","https://www.gsk.com/en-gb/locations/indonesia/","https://jp.gsk.com/ja-jp/","https://kr.gsk.com/ko-kr/","https://www.gsk.com/en-gb/locations/myanmar/","https://pk.gsk.com/en-pk/","https://www.gsk.com/en-gb/locations/new-zealand/","https://www.gsk.com/en-gb/locations/philippines/","https://www.gsk.com/en-gb/locations/singapore/","https://www.gsk.com/en-gb/locations/sri-lanka/","https://tw.gsk.com/zh-tw/","https://www.gsk.com/en-gb/locations/thailand/","https://www.gsk.com/en-gb/locations/uzbekistan/","https://www.gsk.com/en-gb/locations/vietnam/","https://www.gsk.com/en-gb/locations/albania/","https://www.gsk.com/en-gb/locations/austria/","https://www.gsk.com/en-gb/locations/austria/de-aut/","https://www.gsk.com/en-gb/locations/belarus/","https://be.gsk.com/en-be/","https://be.gsk.com/nl-be/","https://be.gsk.com/fr-be/","https://www.gsk.com/en-gb/locations/bosnia-herz/","https://www.gsk.com/en-gb/locations/bulgaria/","https://www.gsk.com/en-gb/locations/bulgaria/bg-bg/","https://www.gsk.com/en-gb/locations/croatia/","https://www.gsk.com/en-gb/locations/cyprus/","https://www.gsk.com/en-gb/locations/czech-republic/","https://www.gsk.com/en-gb/locations/czech-republic/cs-cze/","https://www.gsk.com/en-gb/locations/denmark/","https://www.gsk.com/en-gb/locations/denmark/da-dk/","https://www.gsk.com/en-gb/locations/estonia/","https://www.gsk.com/en-gb/locations/finland/","https://www.gsk.com/en-gb/locations/finland/fi-fi/","https://fr.gsk.com/fr-fr/","https://www.gsk.com/en-gb/locations/georgia/","https://de.gsk.com/de-de/","https://www.gsk.com/en-gb/locations/greece/","https://www.gsk.com/en-gb/locations/greece/gr-grc/","https://www.gsk.com/en-gb/locations/hungary/","https://www.gsk.com/en-gb/locations/hungary/hu-hu/","https://www.gsk.com/en-gb/locations/ireland/","https://it.gsk.com/it-it/","https://www.gsk.com/en-gb/locations/latvia/","https://www.gsk.com/en-gb/locations/latvia/lv-lv/","https://www.gsk.com/en-gb/locations/lithuania/","https://www.gsk.com/en-gb/locations/malta/","https://www.gsk.com/en-gb/locations/moldova/","https://www.gsk.com/en-gb/locations/netherlands/","https://www.gsk.com/en-gb/locations/netherlands/nl-nl/","https://www.gsk.com/en-gb/locations/north-macedonia/","https://www.gsk.com/en-gb/locations/norway/","https://www.gsk.com/en-gb/locations/norway/nb-nor/","https://pl.gsk.com/pl-pl/","https://pt.gsk.com/pt-pt/","https://www.gsk.com/en-gb/locations/romania/","https://www.gsk.com/en-gb/locations/romania/ro-ro/","https://ru.gsk.com/ru-ru/","https://www.gsk.com/en-gb/locations/serbia/","https://www.gsk.com/en-gb/locations/serbia/sr-rs/","https://www.gsk.com/en-gb/locations/slovakia/","https://www.gsk.com/en-gb/locations/slovakia/sk-sk/","https://www.gsk.com/en-gb/locations/slovenia/","https://es.gsk.com/es-es/","https://www.gsk.com/en-gb/locations/sweden/","https://www.gsk.com/en-gb/locations/sweden/sv-se/","https://www.gsk.com/en-gb/locations/switzerland/","https://www.gsk.com/en-gb/locations/switzerland/de-ch/","https://www.gsk.com/en-gb/locations/switzerland/fr-ch/","https://tr.gsk.com/tr-tr/","https://www.gsk.com/en-gb/locations/ukraine/","https://www.gsk.com/en-gb/locations/ukraine/uk-ukr/","https://www.gsk.com/en-gb/locations/united-kingdom/","https://gskpro.com/nl-be/","https://gsk.i-sight.com/landing-page/","https://www.gsk.com/en-gb/company/policy-positions/#","https://www.youtube.com/watch?v=l4A70OmEPSk","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2021/","https://www.gsk.com/en-gb/responsibility/","https://www.youtube.com/embed/wu_LEl0HSvs","https://www.youtube.com/embed/ibGWPULYxdM?reloads=1&uach=WyJXaW5kb3dzIiwiMTAuMC4wIiwieDg2IiwiIiwiMTA3LjAuNTMwNC4xMjEiLFtdLGZhbHNlLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTA3LjAuNTMwNC4xMjEiXSxbIkNocm9taXVtIiwiMTA3LjAuNTMwNC4xMjEiXSxbIk5vdD1BP0JyYW5kIiwiMjQuMC4wLjAiXV0sZmFsc2Vd&uats=1669725250238","https://www.gsk.com/en-gb/behind-the-science-magazine/","https://workmyway.avature.net/en_US/GSKFreelancerPool/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://www.gsk.com/en-gb/","https://www.gsk.com/en-gb","https://www.youtube.com/watch?v=l4A70OmEPSk","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.youtube.com/embed/wu_LEl0HSvs","https://www.youtube.com/embed/ibGWPULYxdM?reloads=1&uach=WyJXaW5kb3dzIiwiMTAuMC4wIiwieDg2IiwiIiwiMTA3LjAuNTMwNC4xMjEiLFtdLGZhbHNlLG51bGwsIjY0IixbWyJHb29nbGUgQ2hyb21lIiwiMTA3LjAuNTMwNC4xMjEiXSxbIkNocm9taXVtIiwiMTA3LjAuNTMwNC4xMjEiXSxbIk5vdD1BP0JyYW5kIiwiMjQuMC4wLjAiXV0sZmFsc2Vd&uats=1669725250238","https://www.youtube.com/watch?v=eAcsp-ZLTs0&list=PLvDyxtKlIcngQ4CRsZA_ROrb_WwxF_Irf&index=2&t=2s","https://www.info.gsk.com/fr-be/pathologie/respiratoire/bpco/","https://workmyway.avature.net/en_US/GSKFreelancerPool/","https://gskpro.com/nl-be/","https://www.gsk.com/en-gb/innovation/pipeline/","https://ng.gsk.com/en-ng/"]},"settings":{"optionalStylesheetLink":null,"themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://be.gsk.com/media/gjtfanix/gsk-logo-2.png?width=104&format=webp&quality=100&v=1dc52f450669430","alt":"GSK logo","darkModeSrc":"https://be.gsk.com/media/gjtfanix/gsk-logo-2.png?width=104&format=webp&quality=90&v=1dc52f450669430"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"S'ouvre dans une nouvelle fenêtre"},"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK Belgium"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Retour en haut de page","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://be.gsk.com/fr-be/medias/communiques-de-presse/la-belgique-en-premiere-ligne-contre-le-paludisme/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":null}